CAJ | 학술논문

对非小细胞肺癌分子病理学的深入理解，有助于开展个性化临床治疗和预后。基因检测可以指导非小细胞肺癌靶向药物治疗，提升药物疗效，延长患者生存期。本文简要介绍了与非小细胞肺癌相关的EGFR基因和EML4-ALK融合基因检测方法的研究进展。
대비소세포폐암분자병이학적심입리해，유조우개전개성화림상치료화예후。기인검측가이지도비소세포폐암파향약물치료，제승약물료효，연장환자생존기。본문간요개소료여비소세포폐암상관적EGFR기인화EML4-ALK융합기인검측방법적연구진전。
The appropriate understanding of the molecular pathology of non-small cell lung carcinomas facilitates the clinically individual therapy and prognosis.The gene detection can direct the targeted-drug therapy,augment curative effect,and extend patient life in non-small cell lung carcinomas.This paper reviews the detective methods for non-small cell lung carcinomas-associated EGFR gene and EML4-ALK fusion gene .